首页> 外国专利> SEQUENTIAL THERAPY COMPRISING A 20(S)-CAMPTOTHECIN COMPOUND AND A PYRIMIDINE BASE ANALOG

SEQUENTIAL THERAPY COMPRISING A 20(S)-CAMPTOTHECIN COMPOUND AND A PYRIMIDINE BASE ANALOG

机译:序贯疗法由20(S)-喜树碱化合物和嘧啶类比类似物组成

摘要

A method is provided for treating a patient having a disease associated withundesirable or uncontrolled cell proliferation, the method comprising:administering to the patient a 20(S)-camptothecin compound for a period oftime during which a pyrimidine base analog is not being administered to thepatient; and administering a pyrimidine base analog to the patient.
机译:提供了一种用于治疗患有以下疾病的患者的方法:不良或不受控制的细胞增殖,该方法包括:给患者服用20(S)-喜树碱化合物的时间为嘧啶碱基类似物未施予的时间患者;向患者施用嘧啶碱基类似物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号